Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Pharmaceutical aspects of medicated myopia control].
Avetisov SE, Fisenko VP, Zhuravlev AS, Agaeva LM. Avetisov SE, et al. Among authors: fisenko vp. Vestn Oftalmol. 2020;136(4. Vyp. 2):310-316. doi: 10.17116/oftalma2020136042310. Vestn Oftalmol. 2020. PMID: 32880156 Russian.
[Atropine use for the prevention of myopia progression].
Avetisov SE, Fisenko VP, Zhuravlev AS, Avetisov KS. Avetisov SE, et al. Among authors: fisenko vp. Vestn Oftalmol. 2018;134(4):84-90. doi: 10.17116/oftalma201813404184. Vestn Oftalmol. 2018. PMID: 30166516 Russian.
Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Makhaeva GF, Lushchekina SV, Kovaleva NV, Yu Astakhova T, Boltneva NP, Rudakova EV, Serebryakova OG, Proshin AN, Serkov IV, Trofimova TP, Tafeenko VA, Radchenko EV, Palyulin VA, Fisenko VP, Korábečný J, Soukup O, Richardson RJ. Makhaeva GF, et al. Among authors: fisenko vp. Bioorg Chem. 2021 Jul;112:104974. doi: 10.1016/j.bioorg.2021.104974. Epub 2021 May 21. Bioorg Chem. 2021. PMID: 34029971
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.
Sychev DA, Sokolov AV, Reshetko OV, Fisenko VP, Sychev IN, Grishina EA, Bochkov PO, Shevchenko RV, Abdullaev SP, Denisenko NP, Ivashchenko DV, Sozaeva ZA, Kachanova AA. Sychev DA, et al. Among authors: fisenko vp. Pharmacogenet Genomics. 2022 Dec 1;32(9):301-307. doi: 10.1097/FPC.0000000000000483. Epub 2022 Oct 13. Pharmacogenet Genomics. 2022. PMID: 36256705
Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach.
Neganova ME, Klochkov SG, Petrova LN, Shevtsova EF, Afanasieva SV, Chudinova ES, Fisenko VP, Bachurin SO, Barreto GE, Aliev G. Neganova ME, et al. Among authors: fisenko vp. CNS Neurol Disord Drug Targets. 2017;16(3):351-355. doi: 10.2174/1871527315666161107090525. CNS Neurol Disord Drug Targets. 2017. PMID: 27823572
Pro-neurogenic, Memory-Enhancing and Anti-stress Effects of DF302, a Novel Fluorine Gamma-Carboline Derivative with Multi-target Mechanism of Action.
Strekalova T, Bahzenova N, Trofimov A, Schmitt-Böhrer AG, Markova N, Grigoriev V, Zamoyski V, Serkova T, Redkozubova O, Vinogradova D, Umriukhin A, Fisenko V, Lillesaar C, Shevtsova E, Sokolov V, Aksinenko A, Lesch KP, Bachurin S. Strekalova T, et al. Mol Neurobiol. 2018 Jan;55(1):335-349. doi: 10.1007/s12035-017-0745-6. Mol Neurobiol. 2018. PMID: 28856531
Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases.
Bachurin SO, Makhaeva GF, Shevtsova EF, Boltneva NP, Kovaleva NV, Lushchekina SV, Rudakova EV, Dubova LG, Vinogradova DV, Sokolov VB, Aksinenko AY, Fisenko VP, Richardson RJ, Aliev G. Bachurin SO, et al. Among authors: fisenko vp. Sci Rep. 2019 Mar 19;9(1):4873. doi: 10.1038/s41598-019-41272-4. Sci Rep. 2019. PMID: 30890752 Free PMC article.
72 results